Cary Nobles Robertson | Scholars@Duke

Cary Nobles Robertson
Associate Professor of Surgery

1. High Intensity Focused Ultrasound Therapy of Prostate Cancer
2. Surgical Technique Improvement in Prostate Cancer
3. Clinical Predictors of Outcome in Prostate Cancer
4. Molecular Imaging and Genomics of Genitourinary Malignancies
5. Quality of Life measures in Genitourinary Malignancies

Current Appointments & Affiliations

Associate Professor of Surgery, Surgery, Urology, Surgery 1998

Contact Information

Box 3707 DUMC Rm 1572E Duke South, 40 Medicine Circle, Durham, NC 27710
DUMC 3707, Durham, NC 27710
cary.robertson@duke.edu (919) 684-5057

Background
Education, Training, & Certifications
- Senior Investigator- Fellowship, Urologic Oncology, National Cancer Institute 1987 - 1988
- Fellowship, Urologic Oncology, National Cancer Institute 1985 - 1987
- Residency, Urologic Surgery, Duke University 1981 - 1985
- Residency, Surgery, Duke University 1980 - 1981
- Residency, Surgery, University of Oregon 1977 - 1978
- M.D., Tulane University 1977
Previous Appointments & Affiliations
- Associate Professor of Urology in the Department of Surgery, Surgery, Urology, Surgery 1995 - 1998
- Assistant Professor of Urology in the Department of Surgery, Surgery, Urology, Surgery 1988 - 1994
Recognition
In the News
- OCT 15, 2013 The People’s Pharmacy
  
  Pushing the envelope on prostate cancer diagnosis and treatment
Expertise
Global Scholarship
- Research
  - Canada (Country)
Research
Selected Grants
- A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of Apalutamide in Subjects with High-risk, Localized or Locally Advanced Prostate Cancer Who are Candidates for Radical Prostatectomy awarded by Janssen Research & Development, LLC 2020 - 2021
External Relationships
- American HIFU Inc.
- EDAP Technomed, Inc
- Innovasc Inc
- Janssen Pharmaceuticals
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Marra, Giancarlo, Maria P. Laguna, Jochen Walz, Christian P. Pavlovich, Fernando Bianco, Justin Gregg, Amir H. Lebastchi, et al. “Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society.” Minerva Urol Nephrol 74, no. 5 (October 2022): 581–89. https://doi.org/10.23736/S2724-6051.20.04160-0.
    Full Text Link to Item
  - Berger, Miles, Jeffrey N. Browndyke, Mary Cooter Wright, Chloe Nobuhara, Melody Reese, Leah Acker, W Michael Bullock, et al. “Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers.” Ann Clin Transl Neurol 9, no. 2 (February 2022): 155–70. https://doi.org/10.1002/acn3.51499.
    Full Text Open Access Copy Link to Item
  - Bakavicius, Arnas, Giancarlo Marra, Petr Macek, Cary Robertson, Andre L. Abreu, Arvin K. George, Bernard Malavaud, et al. “Available evidence on HIFU for focal treatment of prostate cancer: a systematic review.” Int Braz J Urol 48, no. 2 (2022): 263–74. https://doi.org/10.1590/S1677-5538.IBJU.2021.0091.
    Full Text Link to Item
  - Browndyke, Jeffrey N., Mary C. Wright, Rosa Yang, Ayesha Syed, John Park, Ashley Hall, Katherine Martucci, et al. “Perioperative neurocognitive and functional neuroimaging trajectories in older APOE4 carriers compared with non-carriers: secondary analysis of a prospective cohort study.” Br J Anaesth 127, no. 6 (December 2021): 917–28. https://doi.org/10.1016/j.bja.2021.08.012.
    Full Text Open Access Copy Link to Item
  - Terrando, Niccolò, John J. Park, Michael Devinney, Cliburn Chan, Mary Cooter, Pallavi Avasarala, Joseph P. Mathew, et al. “Immunomodulatory lipid mediator profiling of cerebrospinal fluid following surgery in older adults.” Sci Rep 11, no. 1 (February 4, 2021): 3047. https://doi.org/10.1038/s41598-021-82606-5.
    Full Text Open Access Copy Link to Item
  - VanDusen, Keith W., Yi-Ju Li, Victor Cai, Ashley Hall, Sarah Hiles, J Will Thompson, M Arthur Moseley, et al. “Cerebrospinal Fluid Proteome Changes in Older Non-Cardiac Surgical Patients with Postoperative Cognitive Dysfunction.” J Alzheimers Dis 80, no. 3 (2021): 1281–97. https://doi.org/10.3233/JAD-201544.
    Full Text Open Access Copy Link to Item
  - Nobuhara, Chloe K., W Michael Bullock, Thomas Bunning, Brian Colin, Mary Cooter, Michael J. Devinney, Michael N. Ferrandino, et al. “A protocol to reduce self-reported pain scores and adverse events following lumbar punctures in older adults.” J Neurol 267, no. 7 (July 2020): 2002–6. https://doi.org/10.1007/s00415-020-09797-1.
    Full Text Link to Item
  - VanDusen, Keith W., Sarada Eleswarpu, Eugene W. Moretti, Michael J. Devinney, Donna M. Crabtree, Daniel T. Laskowitz, Marty G. Woldorff, et al. “The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction.” J Alzheimers Dis 75, no. 4 (2020): 1319–28. https://doi.org/10.3233/JAD-191185.
    Full Text Open Access Copy Link to Item
  - Varner, Sydneyjane, Gillian Lloyd, Krista W. Ranby, Stephanie Callan, Cary Robertson, and Isaac M. Lipkus. “Illness uncertainty, partner support, and quality of life: A dyadic longitudinal investigation of couples facing prostate cancer.” Psychooncology 28, no. 11 (November 2019): 2188–94. https://doi.org/10.1002/pon.5205.
    Full Text Link to Item
  - Berger, Miles, David M. Murdoch, Janet S. Staats, Cliburn Chan, Jake P. Thomas, Grant E. Garrigues, Jeffrey N. Browndyke, et al. “Flow Cytometry Characterization of Cerebrospinal Fluid Monocytes in Patients With Postoperative Cognitive Dysfunction: A Pilot Study.” Anesth Analg 129, no. 5 (November 2019): e150–54. https://doi.org/10.1213/ANE.0000000000004179.
    Full Text Open Access Copy Link to Item
  - Aminsharifi, Alireza, Ross Simon, Thomas J. Polascik, Cary N. Robertson, Debra L. Sudan, Bradley H. Collins, and Judd W. Moul. “Evaluation and Active Treatment versus Active Surveillance of Localized Prostate Cancer in Renal Transplant Patients in the Era of Low and Very Low Risk Prostate Cancer.” J Urol 202, no. 3 (September 2019): 469–74. https://doi.org/10.1097/JU.0000000000000207.
    Full Text Link to Item
  - Tay, K. J., M. J. Scheltema, H. U. Ahmed, E. Barret, J. A. Coleman, J. Dominguez-Escrig, S. Ghai, et al. “Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project.” Prostate Cancer Prostatic Dis 20, no. 3 (September 2017): 294–99. https://doi.org/10.1038/pcan.2017.8.
    Full Text Link to Item
  - Crouzet, Sebastien, Andreas Blana, Francois J. Murat, Gilles Pasticier, Stephen C. W. Brown, Giario N. Conti, Roman Ganzer, et al. “Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients.” Bju Int 119, no. 6 (June 2017): 896–904. https://doi.org/10.1111/bju.13766.
    Full Text Link to Item
  - Schulman, Ariel A., Kae Jack Tay, Cary N. Robertson, and Thomas J. Polascik. “High-intensity focused ultrasound for focal therapy: reality or pitfall?” Curr Opin Urol 27, no. 2 (March 2017): 138–48. https://doi.org/10.1097/MOU.0000000000000372.
    Full Text Link to Item
  - Giattino, Charles M., Jacob E. Gardner, Faris M. Sbahi, Kenneth C. Roberts, Mary Cooter, Eugene Moretti, Jeffrey N. Browndyke, et al. “Intraoperative Frontal Alpha-Band Power Correlates with Preoperative Neurocognitive Function in Older Adults.” Front Syst Neurosci 11 (2017): 24. https://doi.org/10.3389/fnsys.2017.00024.
    Full Text Open Access Copy Link to Item
  - Ross, Kaile M., Krista W. Ranby, Jennalee S. Wooldridge, Cary Robertson, and Isaac M. Lipkus. “Effects of physical and mental health on relationship satisfaction: a dyadic, longitudinal examination of couples facing prostate cancer.” Psychooncology 25, no. 8 (August 2016): 898–904. https://doi.org/10.1002/pon.3931.
    Full Text Link to Item
  - Muller, B. G., W. van den Bos, M. Brausi, J. J. Fütterer, S. Ghai, P. A. Pinto, I. V. Popeneciu, et al. “Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project.” World J Urol 33, no. 10 (October 2015): 1503–9. https://doi.org/10.1007/s00345-014-1475-2.
    Full Text Link to Item
  - Bailey, Donald E., Meredith Wallace Kazer, Thomas J. Polascik, and Cary Robertson. “Psychosocial trajectories of men monitoring prostate-specific antigen levels following surgery for prostate cancer.” Oncol Nurs Forum 41, no. 4 (July 1, 2014): 361–68. https://doi.org/10.1188/14.ONF.361-368.
    Full Text Link to Item
  - Habib, Ashraf S., Judd W. Moul, Thomas J. Polascik, Cary N. Robertson, Anthony M. Roche, William D. White, Stephen E. Hill, Israel Nosnick, Tong J. Gan, and Tong J. Duke Perioperative Outcome Study Group. “Low central venous pressure versus acute normovolemic hemodilution versus conventional fluid management for reducing blood loss in radical retropubic prostatectomy: a randomized controlled trial.” Curr Med Res Opin 30, no. 5 (May 2014): 937–43. https://doi.org/10.1185/03007995.2013.877436.
    Full Text Link to Item
  - Kimura, M., L. L. Bañez, T. J. Polascik, R. M. Bernal, L. Gerber, C. N. Robertson, C. F. Donatucci, and J. W. Moul. “Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction.” Andrology 1, no. 2 (March 2013): 256–61. https://doi.org/10.1111/j.2047-2927.2012.00036.x.
    Full Text Link to Item
  - Blana, A., C. N. Robertson, S. C. W. Brown, C. Chaussy, S. Crouzet, A. Gelet, G. N. Conti, et al. “Complete high-intensity focused ultrasound in prostate cancer: outcome from the @-Registry.” Prostate Cancer Prostatic Dis 15, no. 3 (September 2012): 256–59. https://doi.org/10.1038/pcan.2012.10.
    Full Text Link to Item
  - Wattson, Daniel A., Ming-Hui Chen, Brian J. Moran, Daniel E. Dosoretz, Michelle H. Braccioforte, Sharon A. Salenius, and Anthony V. D’Amico. “The number of high-risk factors and the risk of prostate cancer-specific mortality after brachytherapy: implications for treatment selection.” Int J Radiat Oncol Biol Phys 82, no. 5 (April 1, 2012): e773–79. https://doi.org/10.1016/j.ijrobp.2011.11.023.
    Full Text Link to Item
  - Singh, A. A., L. L. Banez, L. Gerber, S. J. Freedland, C. N. Robertson, M. Ferrandino, T. Polascik, P. J. Walther, and J. W. Moul. “Perineural versus lymphovascular invasion: Which is a better marker for unfavorable biochemical outcomes following prostatectomy? Results from the Duke Prostate Center Database.” J Clin Oncol 30, no. 5_suppl (February 10, 2012): 34.
    Link to Item
  - Singh, A. A., L. L. Banez, L. Gerber, S. J. Freedland, C. N. Robertson, M. Ferrandino, T. Polascik, P. J. Walther, and J. W. Moul. “Perineural versus lymphovascular invasion: Which is a better marker for unfavorable biochemical outcomes following prostatectomy? Results from the Duke Prostate Center Database.” J Clin Oncol 30, no. 5_suppl (February 10, 2012): 34. https://doi.org/10.1200/jco.2012.30.5_suppl.34.
    Full Text Link to Item
  - Stewart, Suzanne Biehn, Lionel L. Bañez, Cary N. Robertson, Stephen J. Freedland, Thomas J. Polascik, Donghua Xie, Bridget F. Koontz, et al. “Utilization trends at a multidisciplinary prostate cancer clinic: initial 5-year experience from the Duke Prostate Center.” J Urol 187, no. 1 (January 2012): 103–8. https://doi.org/10.1016/j.juro.2011.09.040.
    Full Text Link to Item
  - Huang, Xiaoyi, Fang Yuan, Meihua Liang, Hui-Wen Lo, Mari L. Shinohara, Cary Robertson, and Pei Zhong. “M-HIFU inhibits tumor growth, suppresses STAT3 activity and enhances tumor specific immunity in a transplant tumor model of prostate cancer.” Plos One 7, no. 7 (2012): e41632. https://doi.org/10.1371/journal.pone.0041632.
    Full Text Open Access Copy Link to Item
  - Ganzer, Roman, Cary N. Robertson, John F. Ward, Stephen C. W. Brown, Giario N. Conti, Francois J. Murat, Gilles Pasticier, et al. “Correlation of prostate-specific antigen nadir and biochemical failure after high-intensity focused ultrasound of localized prostate cancer based on the Stuttgart failure criteria - analysis from the @-Registry.” Bju Int 108, no. 8 Pt 2 (October 2011): E196–201. https://doi.org/10.1111/j.1464-410X.2011.10091.x.
    Full Text Link to Item
  - Kimura, Masaki, Lionel L. Bañez, Florian R. Schroeck, Leah Gerber, Jim Qi, Takefumi Satoh, Shiro Baba, et al. “Factors predicting early and late phase decline of sexual health-related quality of life following radical prostatectomy.” J Sex Med 8, no. 10 (October 2011): 2935–43. https://doi.org/10.1111/j.1743-6109.2011.02387.x.
    Full Text Link to Item
  - Motzer, Robert J., Neeraj Agarwal, Clair Beard, Sam Bhayani, Graeme B. Bolger, Michael A. Carducci, Sam S. Chang, et al. “Kidney cancer.” J Natl Compr Canc Netw 9, no. 9 (September 1, 2011): 960–77. https://doi.org/10.6004/jnccn.2011.0082.
    Full Text Link to Item
  - Cotter, Shane E., Ming Hui Chen, Judd W. Moul, W Robert Lee, Bridget F. Koontz, Mitchell S. Anscher, Cary N. Robertson, Philip J. Walther, Thomas J. Polascik, and Anthony V. D’Amico. “Salvage radiation in men after prostate-specific antigen failure and the risk of death.” Cancer 117, no. 17 (September 1, 2011): 3925–32. https://doi.org/10.1002/cncr.25993.
    Full Text Link to Item
  - Tang, Ping, Leon Sun, Matthew A. Uhlman, Cary N. Robertson, Thomas J. Polascik, and Judd W. Moul. “Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men.” Bju Int 108, no. 1 (July 2011): 44–48. https://doi.org/10.1111/j.1464-410X.2010.09812.x.
    Full Text Link to Item
  - Masko, Elizabeth M., Daniel M. Moreira, Lionel L. Banez, Cathrine Hoyo, Delores J. Grant, Elizabeth E. Calloway, Kathleen H. Shuler, et al. “Abstract 2767: Genetic variation in obesity-related genes ADBR2, ADBR3, GHRL, HSD11B1, and SHC1 and risk of prostate cancer: A VA case-control study.” Cancer Research 71, no. 8_Supplement (April 15, 2011): 2767–2767. https://doi.org/10.1158/1538-7445.am2011-2767.
    Full Text
  - Tsivian, Matvey, Vladimir Mouraviev, David M. Albala, Jorge R. Caso, Cary N. Robertson, John F. Madden, and Thomas J. Polascik. “Clinical predictors of renal mass pathological features.” Bju Int 107, no. 5 (March 2011): 735–40. https://doi.org/10.1111/j.1464-410X.2010.09629.x.
    Full Text Link to Item
  - D’Amico, Anthony V., Ming-Hui Chen, Leon Sun, W Robert Lee, Vladimir Mouraviev, Cary N. Robertson, Philip J. Walther, Thomas J. Polascik, David M. Albala, and Judd W. Moul. “Adjuvant versus salvage radiation therapy for prostate cancer and the risk of death.” Bju Int 106, no. 11 (December 2010): 1618–22. https://doi.org/10.1111/j.1464-410X.2010.09447.x.
    Full Text Link to Item
  - Tang, Ping, Leon Sun, Matthew A. Uhlman, Cary N. Robertson, Thomas J. Polascik, David M. Albala, Craig F. Donatucci, and Judd W. Moul. “Prostate-specific antigen-based risk-adapted discontinuation of prostate cancer screening in elderly African American and Caucasian American men.” Urology 76, no. 5 (November 2010): 1058–62. https://doi.org/10.1016/j.urology.2009.09.049.
    Full Text Link to Item
  - Caire, A. A., L. Sun, B. D. Lack, K. Lum, P. Tang, D. A. Stackhouse, C. N. Robertson, et al. “Predicting non-organ-confined prostate cancer in men diagnosed after 2000.” Prostate Cancer Prostatic Dis 13, no. 3 (September 2010): 248–51. https://doi.org/10.1038/pcan.2010.15.
    Full Text Link to Item
  - Tsivian, Matvey, Daniel M. Moreira, Jorge R. Caso, Vladimir Mouraviev, John F. Madden, Gennady Bratslavsky, Cary N. Robertson, David M. Albala, and Thomas J. Polascik. “Predicting occult multifocality of renal cell carcinoma.” Eur Urol 58, no. 1 (July 2010): 118–26. https://doi.org/10.1016/j.eururo.2010.03.011.
    Full Text Link to Item
  - Caire, Arthur A., Leon Sun, Cary N. Robertson, Thomas J. Polascik, Kelly E. Maloney, Daniel J. George, Marva M. Price, et al. “Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75.” Urology 75, no. 5 (May 2010): 1122–27. https://doi.org/10.1016/j.urology.2009.06.091.
    Full Text Link to Item
  - Choueiri, Toni K., Ming-Hui Chen, Anthony V. D’Amico, Leon Sun, Paul L. Nguyen, Julia H. Hayes, Cary N. Robertson, et al. “Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death.” Cancer 116, no. 8 (April 15, 2010): 1887–92. https://doi.org/10.1002/cncr.25013.
    Full Text Link to Item
  - Uhlman, Matthew A., Leon Sun, Danielle A. Stackhouse, Thomas J. Polascik, Valdmir Mouraviev, Cary N. Robertson, David M. Albala, and Judd W. Moul. “Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate.” J Urol 183, no. 3 (March 2010): 997–1001. https://doi.org/10.1016/j.juro.2009.11.046.
    Full Text Link to Item
  - Tang, Ping, Leon Sun, Matthew A. Uhlman, Cary N. Robertson, Thomas J. Polascik, David M. Albala, Craig F. Donatucci, and Judd W. Moul. “Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk.” J Urol 183, no. 3 (March 2010): 946–50. https://doi.org/10.1016/j.juro.2009.11.021.
    Full Text Link to Item
  - Uhlman, Matthew A., Leon Sun, Danielle A. Stackhouse, Arthur A. Caire, Thomas J. Polascik, Cary N. Robertson, John Madden, Robin Vollmer, David M. Albala, and Judd W. Moul. “Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?” Urology 75, no. 2 (February 2010): 460–66. https://doi.org/10.1016/j.urology.2009.06.059.
    Full Text Link to Item
  - Sun, Leon, Arthur A. Caire, Cary N. Robertson, Daniel J. George, Thomas J. Polascik, Kelly E. Maloney, Philip J. Walther, et al. “Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras.” J Urol 182, no. 5 (November 2009): 2242–48. https://doi.org/10.1016/j.juro.2009.07.034.
    Full Text Link to Item
  - Blana, Andreas, Stephen C. W. Brown, Christian Chaussy, Giario N. Conti, James A. Eastham, Roman Ganzer, Francois J. Murat, et al. “High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.” Bju Int 104, no. 8 (October 2009): 1058–62. https://doi.org/10.1111/j.1464-410X.2009.08518.x.
    Full Text Link to Item
  - Uhlman, M. A., J. W. Moul, C. N. Robertson, and L. Sun. “Prostate-specific antigen screening and prostate cancer mortality: Implications of a randomized European study.” Aging Health 5, no. 3 (September 18, 2009): 281–86. https://doi.org/10.2217/ahe.09.29.
    Full Text
  - Caire, Arthur A., Leon Sun, Oludotun Ode, Danielle A. Stackhouse, Kelly Maloney, Craig Donatucci, Vladimir Mouraviev, et al. “Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?” Urology 74, no. 3 (September 2009): 643–47. https://doi.org/10.1016/j.urology.2009.02.049.
    Full Text Link to Item
  - Xu, David D., Sandy D. Sun, Flint Wang, Leon Sun, Danielle Stackhouse, Thomas Polascik, David M. Albala, Judd W. Moul, Arthur Caire, and Cary N. Robertson. “Effect of age and pathologic Gleason score on PSA recurrence: analysis of 2911 patients undergoing radical prostatectomy.” Urology 74, no. 3 (September 2009): 654–58. https://doi.org/10.1016/j.urology.2008.12.063.
    Full Text Link to Item
  - D’Alonzo, Richard C., Tong J. Gan, Judd W. Moul, David M. Albala, Thomas J. Polascik, Cary N. Robertson, Leon Sun, Philipp Dahm, and Ashraf S. Habib. “A retrospective comparison of anesthetic management of robot-assisted laparoscopic radical prostatectomy versus radical retropubic prostatectomy.” J Clin Anesth 21, no. 5 (August 2009): 322–28. https://doi.org/10.1016/j.jclinane.2008.09.005.
    Full Text Link to Item
  - Stackhouse, Danielle A., Leon Sun, Florian R. Schroeck, Jayakrishnan Jayachandran, Arthur A. Caire, Cyril O. Acholo, Cary N. Robertson, et al. “Factors predicting prostatic biopsy Gleason sum under grading.” J Urol 182, no. 1 (July 2009): 118–22. https://doi.org/10.1016/j.juro.2009.02.127.
    Full Text Link to Item
  - Caire, Arthur A., Leon Sun, Thomas J. Polascik, Cary N. Robertson, Kelly E. Maloney, Craig F. Donatucci, Daivd M. Albala, and Judd W. Moul. “PREDICTING NON-ORGAN CONFINED PROSTATE CANCER AFTER THE YEAR 2000.” The Journal of Urology 181, no. 4 (April 2009): 609–609. https://doi.org/10.1016/s0022-5347(09)61710-9.
    Full Text
  - Lack, Benjamin D., Leon Sun, Arthur A. Caire, Craig F. Donatucci, Cary N. Robertson, Vladimir Mouraviev, Thomas J. Polascik, et al. “WHO DOES NOT NEED FOLLOW UP TWO YEARS AFTER PROSTATECTOMY? AN ANALYSIS OF 1739 PATIENTS AT DUKE UNIVERSITY MEDICAL CENTER.” Journal of Urology 181, no. 4S (April 2009): 759–759. https://doi.org/10.1016/s0022-5347(09)62115-7.
    Full Text
  - Lack, Benjamin D., Leon Sun, Arthur A. Caire, Oludotun Ode, Danielle A. Stackhouse, Kelly E. Maloney, Craig F. Donatucci, et al. “DELAYED PSA RECURRENCE AFTER RADICAL PROSTATECTOMY: HOW TO IDENTIFY PATIENTS AT RISK AND THEIR CLINICAL OUTCOMES?” Journal of Urology 181, no. 4S (April 2009): 457–457. https://doi.org/10.1016/s0022-5347(09)61296-9.
    Full Text
  - Moul, Judd W., Leon Sun, Benjamin D. Lack, Cary N. Robertson, Thomas J. Polascik, Craig F. Donatucci, Kelly E. Maloney, Marva Price, David M. Albala, and Arthur A. Caire. “SAY NO TO THE US PREVENTATIVE TASK FORCE RECOMMENDATION TO NO LONGER OFFER PROSTATE CANCER SCREENING AFTER AGE 75?” Journal of Urology 181, no. 4S (April 2009): 797–797. https://doi.org/10.1016/s0022-5347(09)62222-9.
    Full Text
  - Stackhouse, Danielle A., Leon Sun, Philipp Dahm, Louis R. Kavoussi, David Paulson, Craig F. Donatucci, Kelly E. Maloney, et al. “PERINEAL RADICAL PROSTATECTOMY: WHAT ARE THE TEN YEAR OUTCOMES?” Journal of Urology 181, no. 4S (April 2009): 210–210. https://doi.org/10.1016/s0022-5347(09)60604-2.
    Full Text
  - Demark-Wahnefried, Wendy, Thomas J. Polascik, Stephen L. George, Boyd R. Switzer, John F. Madden, Mack T. Ruffin, Denise C. Snyder, et al. “Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery.” Cancer Epidemiol Biomarkers Prev 17, no. 12 (December 2008): 3577–87. https://doi.org/10.1158/1055-9965.EPI-08-0008.
    Full Text Link to Item
  - Isariyawongse, Brandon K., Leon Sun, Lionel L. Bañez, Cary Robertson, Thomas J. Polascik, Kelly Maloney, Craig Donatucci, et al. “Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen.” Urology 72, no. 4 (October 2008): 882–86. https://doi.org/10.1016/j.urology.2008.02.021.
    Full Text Link to Item
  - Price, Marva M., Robert J. Hamilton, Cary N. Robertson, Maureen C. Butts, and Stephen J. Freedland. “Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.” Urology 71, no. 5 (May 2008): 787–91. https://doi.org/10.1016/j.urology.2007.11.036.
    Full Text Link to Item
  - Schroeck, F. R., L. Sun, S. J. Freedland, J. Jayachandran, C. N. Robertson, and J. W. Moul. “Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy.” Prostate Cancer Prostatic Dis 11, no. 4 (2008): 371–76. https://doi.org/10.1038/pcan.2008.18.
    Full Text Link to Item
  - Marguet, Charles, Ganesh V. Raj, James H. Brashears, Mitchell S. Anscher, Kirk Ludwig, Vladimir Mouraviev, Cary N. Robertson, and Thomas J. Polascik. “Rectourethral fistula after combination radiotherapy for prostate cancer.” Urology 69, no. 5 (May 2007): 898–901. https://doi.org/10.1016/j.urology.2007.01.044.
    Full Text Link to Item
  - Sun, Leon, Judd W. Moul, James M. Hotaling, Edward Rampersaud, Phillipp Dahm, Cary Robertson, Nicholas Fitzsimons, David Albala, and Thomas J. Polascik. “Prostate-specific antigen (PSA) and PSA velocity for prostate cancer detection in men aged <50 years.” Bju Int 99, no. 4 (April 2007): 753–57. https://doi.org/10.1111/j.1464-410X.2006.06682.x.
    Full Text Link to Item
  - Tseng, Timothy Y., Quinton V. Cancel, Susan F. Fesperman, Hubert R. Kuebler, Leon Sun, Cary N. Robertson, Thomas J. Polascik, et al. “The role of early adopter bias for new technologies in robot assisted laparoscopic prostatectomy.” J Urol 177, no. 4 (April 2007): 1318–23. https://doi.org/10.1016/j.juro.2006.11.035.
    Full Text Link to Item
  - Mouraviev, Vladimir, Israel Nosnik, Cary Robertson, David Albala, Philip Walther, and Thomas J. Polascik. “Comparative financial analysis of minimally invasive surgery to open surgery for small renal tumours < or =3.5 cm: a single institutional experience.” Eur Urol 51, no. 3 (March 2007): 715–20. https://doi.org/10.1016/j.eururo.2006.06.050.
    Full Text Link to Item
  - Moul, Judd W., Leon Sun, James M. Hotaling, Nicholas J. Fitzsimons, Thomas J. Polascik, Cary N. Robertson, Philipp Dahm, et al. “Age adjusted prostate specific antigen and prostate specific antigen velocity cut points in prostate cancer screening.” J Urol 177, no. 2 (February 2007): 499–503. https://doi.org/10.1016/j.juro.2006.09.063.
    Full Text Link to Item
  - Mouraviev, Vladimir, Israel Nosnik, Leon Sun, Cary N. Robertson, Philip Walther, David Albala, Judd W. Moul, and Thomas J. Polascik. “Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience.” Urology 69, no. 2 (February 2007): 311–14. https://doi.org/10.1016/j.urology.2006.10.025.
    Full Text Link to Item
  - Motzer, Robert J., Graeme B. Bolger, Barry Boston, Michael A. Carducci, Mayer Fishman, Steven L. Hancock, Ralph J. Hauke, et al. “Kidney cancer. Clinical practice guidelines in oncology.” J Natl Compr Canc Netw 4, no. 10 (November 2006): 1072–81. https://doi.org/10.6004/jnccn.2006.0089.
    Full Text Link to Item
  - Motzer, Robert J., Graeme B. Bolger, Barry Boston, Michael A. Carducci, Mayer Fishman, Steven L. Hancock, Ralph J. Hauke, et al. “Testicular cancer. Clinical practice guidelines in oncology.” J Natl Compr Canc Netw 4, no. 10 (November 2006): 1038–58. https://doi.org/10.6004/jnccn.2006.0087.
    Full Text Link to Item
  - Anscher, M. S., R. Clough, C. N. Robertson, L. R. Prosnitz, P. Dahm, P. Walther, C. F. Donatucci, et al. “Timing and patterns of recurrences and deaths from prostate cancer following adjuvant pelvic radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate.” Prostate Cancer Prostatic Dis 9, no. 3 (2006): 254–60. https://doi.org/10.1038/sj.pcan.4500903.
    Full Text Link to Item
  - Weizer, Alon Z., Ganesh V. Raj, Martin O’Connell, Cary N. Robertson, Rendon C. Nelson, and Thomas J. Polascik. “Complications after percutaneous radiofrequency ablation of renal tumors.” Urology 66, no. 6 (December 2005): 1176–80. https://doi.org/10.1016/j.urology.2005.06.125.
    Full Text Link to Item
  - Wiygul, Jeremy B., Brian R. Evans, Bercedis L. Peterson, Thomas J. Polascik, Philip J. Walther, Cary N. Robertson, David M. Albala, and Wendy Demark-Wahnefried. “Supplement use among men with prostate cancer.” Urology 66, no. 1 (July 2005): 161–66. https://doi.org/10.1016/j.urology.2005.01.035.
    Full Text Link to Item
  - Motzer, Robert J., Michael A. Carducci, Mayer Fishman, Steven L. Hancock, Ralph J. Hauke, Gary R. Hudes, Philip Kantoff, et al. “Kidney cancer. Clinical practice guidelines.” J Natl Compr Canc Netw 3, no. 1 (January 2005): 84–93.
    Link to Item
  - Motzer, Robert J., Robert R. Bahnson, Barry Boston, Michael A. Carducci, Mayer Fishman, Steven L. Hancock, Ralph J. Hauke, et al. “Testicular cancer. Clinical practice guidelines.” J Natl Compr Canc Netw 3, no. 1 (January 2005): 52–76.
    Link to Item
  - Demark-Wahnefried, Wendy, Cary N. Robertson, Philip J. Walther, Thomas J. Polascik, David F. Paulson, and Robin T. Vollmer. “Pilot study to explore effects of low-fat, flaxseed-supplemented diet on proliferation of benign prostatic epithelium and prostate-specific antigen.” Urology 63, no. 5 (May 2004): 900–904. https://doi.org/10.1016/j.urology.2003.12.010.
    Full Text Link to Item
  - Mishel, Merle H., Barbara B. Germino, Michael Belyea, Janet L. Stewart, Donald E. Bailey, James Mohler, and Cary Robertson. “Moderators of an uncertainty management intervention: for men with localized prostate cancer.” Nurs Res 52, no. 2 (2003): 89–97. https://doi.org/10.1097/00006199-200303000-00005.
    Full Text Link to Item
  - Price, David T., R Edward Coleman, Ray P. Liao, Cary N. Robertson, Thomas J. Polascik, and Timothy R. DeGrado. “Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.” J Urol 168, no. 1 (July 2002): 273–80.
    Link to Item
  - Mishel, Merle H., Michael Belyea, Barbara B. Germino, Janet L. Stewart, Donald E. Bailey, Cary Robertson, and James Mohler. “Helping patients with localized prostate carcinoma manage uncertainty and treatment side effects: nurse-delivered psychoeducational intervention over the telephone.” Cancer 94, no. 6 (March 15, 2002): 1854–66. https://doi.org/10.1002/cncr.10390.
    Full Text Link to Item
  - Young, M. D., P. Dahm, and C. N. Robertson. “Prostatic sarcoma with rapid tumor progression after nerve sparing radical cystoprostatectomy.” J Urol 166, no. 3 (September 2001): 994.
    Link to Item
  - Demark-Wahnefried, W., D. T. Price, T. J. Polascik, C. N. Robertson, E. E. Anderson, D. F. Paulson, P. J. Walther, M. Gannon, and R. T. Vollmer. “Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features.” Urology 58, no. 1 (July 2001): 47–52. https://doi.org/10.1016/s0090-4295(01)01014-7.
    Full Text Link to Item
  - DeGrado, T. R., R. E. Coleman, S. Wang, S. W. Baldwin, M. D. Orr, C. N. Robertson, T. J. Polascik, and D. T. Price. “Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.” Cancer Res 61, no. 1 (January 1, 2001): 110–17.
    Link to Item
  - Ogawa, Y., Y. Nakagami, R. Ishizaki, H. Yoshida, K. M. Parkinson, C. N. Robertson, and D. F. Paulson. “Heat shock protein 70 (HSP70) does not prevent the inhibition of cell growth in DU-145 cells treated with TGF-beta1.” Anticancer Res 21, no. 5 (2001): 3341–47.
    Link to Item
  - Denmark-Wahnefried, W., J. M. Schildkraut, D. Thompson, S. M. Lesko, L. McIntyre, P. Schwingl, D. F. Paulson, C. N. Robertson, E. E. Anderson, and P. J. Walther. “Early onset baldness and prostate cancer risk.” Cancer Epidemiol Biomarkers Prev 9, no. 3 (March 2000): 325–28.
    Link to Item
  - Ahearn, G. S., R. S. Bedlack, D. T. Price, C. N. Robertson, and J. C. Morgenlander. “Transient lumbosacral polyradiculopathy after prostatectomy: association with spinal stenosis.” South Med J 92, no. 8 (August 1999): 809–11. https://doi.org/10.1097/00007611-199908000-00013.
    Full Text Link to Item
  - Kim, S. P., C. L. Bennett, C. Chan, J. Chmiel, D. Falcone, S. J. Knight, T. Kuzel, et al. “QOL and outcomes research in prostate cancer patients with low socioeconomic status.” Oncology (Williston Park) 13, no. 6 (June 1999): 823–32.
    Link to Item
  - Gan, T. J., E. Bennett-Guerrero, B. Phillips-Bute, H. Wakeling, D. M. Moskowitz, Y. Olufolabi, S. N. Konstadt, et al. “Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group.” Anesth Analg 88, no. 5 (May 1999): 992–98. https://doi.org/10.1097/00000539-199905000-00005.
    Full Text Link to Item
  - Padilla-Nash, H. M., W. G. Nash, G. M. Padilla, K. M. Roberson, C. N. Robertson, M. Macville, E. Schröck, and T. Ried. “Molecular cytogenetic analysis of the bladder carcinoma cell line BK-10 by spectral karyotyping.” Genes Chromosomes Cancer 25, no. 1 (May 1999): 53–59. https://doi.org/10.1002/(sici)1098-2264(199905)25:1<53::aid-gcc8>3.0.co;2-t.
    Full Text Link to Item
  - Taylor, J. A., D. M. Umbach, E. Stephens, T. Castranio, D. Paulson, C. Robertson, J. L. Mohler, and D. A. Bell. “The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.” Cancer Res 58, no. 16 (August 15, 1998): 3603–10.
    Link to Item
  - Roberson, K. M., D. R. Yancey, H. Padilla-Nash, D. W. Edwards, W. Nash, S. Jacobs, G. M. Padilla, W. A. Larchian, and C. N. Robertson. “Isolation and characterization of a novel human bladder cancer cell line: BK10.” In Vitro Cell Dev Biol Anim 34, no. 7 (1998): 537–44. https://doi.org/10.1007/s11626-998-0113-y.
    Full Text Link to Item
  - Robertson, C. N., K. M. Roberson, A. Pinero, J. M. Jaynes, and D. F. Paulson. “Peptidyl membrane-interactive molecules are cytotoxic to prostatic cancer cells in vitro.” World J Urol 16, no. 6 (1998): 405–9. https://doi.org/10.1007/s003450050091.
    Full Text Link to Item
  - Iselin, C. E., C. N. Robertson, G. D. Webster, J. Vieweg, and D. F. Paulson. “Does prostate transitional cell carcinoma preclude orthotopic bladder reconstruction after radical cystoprostatectomy for bladder cancer?” J Urol 158, no. 6 (December 1997): 2123–26. https://doi.org/10.1016/s0022-5347(01)68174-6.
    Full Text Link to Item
  - Robertson, C. “Early management of acute severe asthma.” Lancet 349, no. 9057 (April 5, 1997): 1030. https://doi.org/10.1016/S0140-6736(05)62936-4.
    Full Text Link to Item
  - Demark-Wahnefried, W., M. R. Conaway, C. N. Robertson, B. J. Mathias, E. E. Anderson, and D. F. Paulson. “Anthropometric risk factors for prostate cancer.” Nutr Cancer 28, no. 3 (1997): 302–7. https://doi.org/10.1080/01635589709514591.
    Full Text Link to Item
  - Demark-Wahnefried, W., S. M. Lesko, M. R. Conaway, C. N. Robertson, R. V. Clark, B. Lobaugh, B. J. Mathias, T. S. Strigo, and D. F. Paulson. “Serum androgens: associations with prostate cancer risk and hair patterning.” J Androl 18, no. 5 (1997): 495–500.
    Link to Item
  - Dodd, L. G., W. W. Johnston, C. N. Robertson, and L. J. Layfield. “Endoscopic brush cytology of the upper urinary tract. Evaluation of its efficacy and potential limitations in diagnosis.” Acta Cytol 41, no. 2 (1997): 377–84. https://doi.org/10.1159/000332528.
    Full Text Link to Item
  - Roberson, K. M., S. N. Penland, G. M. Padilla, R. S. Selvan, C. S. Kim, R. L. Fine, and C. N. Robertson. “Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.” Cell Growth Differ 8, no. 1 (January 1997): 101–11.
    Link to Item
  - Lo, J., B. J. Kerns, C. L. Amling, C. N. Robertson, and L. J. Layfield. “Correlation of DNA ploidy and histologic diagnosis from prostate core-needle biopsies: is DNA ploidy more sensitive than histology for the diagnosis of carcinoma in small specimens?” J Surg Oncol 63, no. 1 (September 1996): 41–45. https://doi.org/10.1002/(SICI)1096-9098(199609)63:1<41::AID-JSO7>3.0.CO;2-Q.
    Full Text Link to Item
  - Robertson, C. N., K. M. Roberson, G. M. Padilla, E. T. O’Brien, J. M. Cook, C. S. Kim, and R. L. Fine. “Induction of apoptosis by diethylstilbestrol in hormone-insensitive prostate cancer cells.” J Natl Cancer Inst 88, no. 13 (July 3, 1996): 908–17. https://doi.org/10.1093/jnci/88.13.908.
    Full Text Link to Item
  - Canada, A. T., K. M. Roberson, R. L. Vessella, D. L. Trump, C. N. Robertson, and R. L. Fine. “Glutathione and glutathione S-transferase in benign and malignant prostate cell lines and prostate tissues.” Biochem Pharmacol 51, no. 1 (January 12, 1996): 87–90. https://doi.org/10.1016/0006-2952(95)02157-4.
    Full Text Link to Item
  - Roberson, K. M., D. W. Edwards, G. C. Chang, and C. N. Robertson. “Isolation and characterization of a novel human prostatic stromal cell culture: DuK50.” In Vitro Cell Dev Biol Anim 31, no. 11 (December 1995): 840–45. https://doi.org/10.1007/BF02634567.
    Full Text Link to Item
  - Demark-Wahnefried, W., T. Strigo, K. Catoe, M. Conaway, M. Brunetti, B. K. Rimer, and C. N. Robertson. “Knowledge, beliefs, and prior screening behavior among blacks and whites reporting for prostate cancer screening.” Urology 46, no. 3 (September 1995): 346–51. https://doi.org/10.1016/S0090-4295(99)80218-0.
    Full Text Link to Item
  - Anscher, M. S., C. N. Robertson, and R. Prosnitz. “Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update.” Int J Radiat Oncol Biol Phys 33, no. 1 (August 30, 1995): 37–43. https://doi.org/10.1016/0360-3016(95)00038-z.
    Full Text Link to Item
  - Tseng-Crank, J., T. Kost, A. Goetz, S. Hazum, K. M. Roberson, J. Haizlip, N. Godinot, C. N. Robertson, and D. Saussy. “The alpha 1C-adrenoceptor in human prostate: cloning, functional expression, and localization to specific prostatic cell types.” Br J Pharmacol 115, no. 8 (August 1995): 1475–85. https://doi.org/10.1111/j.1476-5381.1995.tb16640.x.
    Full Text Link to Item
  - Vieweg, J., D. Boczkowski, K. M. Roberson, D. W. Edwards, M. Philip, R. Philip, T. Rudoll, C. Smith, C. Robertson, and E. Gilboa. “Efficient gene transfer with adeno-associated virus-based plasmids complexed to cationic liposomes for gene therapy of human prostate cancer.” Cancer Res 55, no. 11 (June 1, 1995): 2366–72.
    Link to Item
  - Roberson, K. M., G. M. Padilla, J. M. Schmidt, V. Petrow, and C. N. Robertson. “6-Methylene progesterone is cytotoxic to human cancer cell lines independent of its 5-alpha-reductase activity.” Prostate 26, no. 1 (January 1995): 28–34. https://doi.org/10.1002/pros.2990260107.
    Full Text Link to Item
  - Robertson, C. N., K. M. Roberson, A. J. Herzberg, B. J. Kerns, R. K. Dodge, and D. F. Paulson. “Differential immunoreactivity of transforming growth factor alpha in benign, dysplastic and malignant prostatic tissues.” Surg Oncol 3, no. 4 (August 1994): 237–42. https://doi.org/10.1016/0960-7404(94)90039-6.
    Full Text Link to Item
  - Demark-Wahnefried, W., K. E. Catoe, E. Paskett, C. N. Robertson, and B. K. Rimer. “Characteristics of men reporting for prostate cancer screening.” Urology 42, no. 3 (September 1993): 269–74. https://doi.org/10.1016/0090-4295(93)90615-h.
    Full Text Link to Item
  - Gomella, L. G., H. Ehya, S. M. Steinberg, M. Rupp, M. Merino, C. Robertson, and W. M. Linehan. “Flow cytometric DNA analysis of interleukin-2 responsive renal cell carcinoma.” J Surg Oncol 53, no. 4 (August 1993): 252–55. https://doi.org/10.1002/jso.2930530413.
    Full Text Link to Item
  - Bell, D. A., J. A. Taylor, D. F. Paulson, C. N. Robertson, J. L. Mohler, and G. W. Lucier. “Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer.” J Natl Cancer Inst 85, no. 14 (July 21, 1993): 1159–64. https://doi.org/10.1093/jnci/85.14.1159.
    Full Text Link to Item
  - Ibrahim, G. K., B. J. Kerns, J. A. MacDonald, S. N. Ibrahim, R. B. Kinney, P. A. Humphrey, and C. N. Robertson. “Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues.” J Urol 149, no. 1 (January 1993): 170–73. https://doi.org/10.1016/s0022-5347(17)36032-9.
    Full Text Link to Item
  - Long, J. P., P. L. Choyke, T. A. Shawker, C. N. Robertson, H. I. Pass, M. M. Wather, and W. M. Linehan. “Intraoperative Ultrasound In The Evaluation Of Tumor Involvement Of The Inferior Vena Cava.” The Journal of Urology 150 (1993): 13–17.
    Link to Item
  - Canada, A., L. Herman, K. Kidd, C. Robertson, and D. Trump. “Glutathione depletion increases the cytotoxicity of melphalan to PC-3, an androgen-insensitive prostate cancer cell line.” Cancer Chemother Pharmacol 32, no. 1 (1993): 73–77. https://doi.org/10.1007/BF00685880.
    Full Text Link to Item
  - Ibrahim, G. K., P. E. Gravitt, K. L. Dittrich, S. N. Ibrahim, O. Melhus, S. M. Anderson, and C. N. Robertson. “Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization.” J Urol 148, no. 6 (December 1992): 1822–26. https://doi.org/10.1016/s0022-5347(17)37040-4.
    Full Text Link to Item
  - Robertson, C., W. Demark-Wahnefried, and T. Aldrich. “Prostate cancer in North Carolina.” N C Med J 53, no. 9 (September 1992): 447–51.
    Link to Item
  - Ibrahim, G. K., J. A. MacDonald, B. J. Kerns, S. N. Ibrahim, P. A. Humphrey, and C. N. Robertson. “Differential immunoreactivity of her-2/neu oncoprotein in prostatic tissues.” Surg Oncol 1, no. 2 (April 1992): 151–55. https://doi.org/10.1016/0960-7404(92)90028-j.
    Full Text Link to Item
  - Paulson, D. F., and C. N. Robertson. “Positive margins: is adjunctive radiation therapy indicated?” Acta Oncol 30, no. 2 (1991): 263–65. https://doi.org/10.3109/02841869109092366.
    Full Text Link to Item
  - Paulson, D. F., and C. N. Robertson. “The relevance of stage A malignancy in prostatic cancer.” Acta Oncol 30, no. 2 (1991): 227–29. https://doi.org/10.3109/02841869109092358.
    Full Text Link to Item
  - Robertson, C. N., and D. F. Paulson. “DNA in radical prostatectomy specimens. Prognostic value of tumor ploidy.” Acta Oncol 30, no. 2 (1991): 205–7. https://doi.org/10.3109/02841869109092351.
    Full Text Link to Item
  - Robertson, C. N., and D. F. Paulson. “Radical surgery versus radiation therapy in early prostatic carcinoma.” Acta Oncol 30, no. 2 (1991): 239–42. https://doi.org/10.3109/02841869109092360.
    Full Text Link to Item
  - Perry, R. R., H. R. Keiser, J. A. Norton, R. T. Wall, C. N. Robertson, W. Travis, H. I. Pass, M. M. Walther, and W. M. Linehan. “Surgical management of pheochromocytoma with the use of metyrosine.” Ann Surg 212, no. 5 (November 1990): 621–28. https://doi.org/10.1097/00000658-199011000-00010.
    Full Text Link to Item
  - Robertson, C. N., W. M. Linehan, H. I. Pass, L. G. Gomella, G. P. Haas, A. Berman, M. Merino, and S. A. Rosenberg. “Preparative cytoreductive surgery in patients with metastatic renal cell carcinoma treated with adoptive immunotherapy with interleukin-2 or interleukin-2 plus lymphokine activated killer cells.” J Urol 144, no. 3 (September 1990): 614–17. https://doi.org/10.1016/s0022-5347(17)39537-x.
    Full Text Link to Item
  - Kennedy, S. M., M. J. Merino, W. M. Linehan, J. R. Roberts, C. N. Robertson, and R. D. Neumann. “Collecting duct carcinoma of the kidney.” Hum Pathol 21, no. 4 (April 1990): 449–56. https://doi.org/10.1016/0046-8177(90)90209-n.
    Full Text Link to Item
  - Robertson, C. N. “Biotherapy and chemotherapy of renal cell carcinoma.” Problems in Urology 4, no. 2 (January 1, 1990): 331–40.
  - Gomella, L. G., P. Anglard, E. R. Sargent, C. N. Robertson, A. Kasid, and W. M. Linehan. “Epidermal growth factor receptor gene analysis in renal cell carcinoma.” J Urol 143, no. 1 (January 1990): 191–93. https://doi.org/10.1016/s0022-5347(17)39908-1.
    Full Text Link to Item
  - Haas, G. P., S. Pittaluga, L. Gomella, W. D. Travis, R. J. Sherins, J. L. Doppman, W. M. Linehan, and C. Robertson. “Clinically occult Leydig cell tumor presenting with gynecomastia.” J Urol 142, no. 5 (November 1989): 1325–27. https://doi.org/10.1016/s0022-5347(17)39077-8.
    Full Text Link to Item
  - Horan, J. J., C. N. Robertson, P. L. Choyke, J. A. Frank, D. L. Miller, H. I. Pass, and W. M. Linehan. “The detection of renal carcinoma extension into the renal vein and inferior vena cava: a prospective comparison of venacavography and magnetic resonance imaging.” J Urol 142, no. 4 (October 1989): 943–47. https://doi.org/10.1016/s0022-5347(17)38948-6.
    Full Text Link to Item
  - Yano, T., M. Linehan, P. Anglard, M. I. Lerman, L. N. Daniel, C. A. Stein, C. N. Robertson, R. LaRocca, and B. Zbar. “Genetic changes in human adrenocortical carcinomas.” J Natl Cancer Inst 81, no. 7 (April 5, 1989): 518–23. https://doi.org/10.1093/jnci/81.7.518.
    Full Text Link to Item
  - Ashby, H., M. DiMattina, W. M. Linehan, C. N. Robertson, J. T. Queenan, and B. D. Albertson. “The inhibition of human adrenal steroidogenic enzyme activities by suramin.” J Clin Endocrinol Metab 68, no. 2 (February 1989): 505–8. https://doi.org/10.1210/jcem-68-2-505.
    Full Text Link to Item
  - Begley, M. G., T. H. Shawker, C. N. Robertson, S. N. Bock, J. P. Wei, and M. T. Lotze. “Fournier gangrene: diagnosis with scrotal US.” Radiology 169, no. 2 (November 1988): 387–89. https://doi.org/10.1148/radiology.169.2.3051115.
    Full Text Link to Item
  - Topalian, S. L., D. Solomon, F. P. Avis, A. E. Chang, D. L. Freerksen, W. M. Linehan, M. T. Lotze, C. N. Robertson, C. A. Seipp, and P. Simon. “Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study.” J Clin Oncol 6, no. 5 (May 1988): 839–53. https://doi.org/10.1200/JCO.1988.6.5.839.
    Full Text Link to Item
  - Linehan, W. M., C. N. Robertson, E. T. Miller, and A. C. Santora. “Evaluation of the paracrine and endocrine effects of genitourinary tumor produced growth factors.” Prog Clin Biol Res 277 (1988): 135–43.
    Link to Item
  - Carson, C. C., and C. N. Robertson. “Late hematogenous infection of penile prostheses.” J Urol 139, no. 1 (January 1988): 50–52. https://doi.org/10.1016/s0022-5347(17)42287-7.
    Full Text Link to Item
  - Rosenberg, S. A., M. T. Lotze, L. M. Muul, A. E. Chang, F. P. Avis, S. Leitman, W. M. Linehan, C. N. Robertson, R. E. Lee, and J. T. Rubin. “A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.” N Engl J Med 316, no. 15 (April 9, 1987): 889–97. https://doi.org/10.1056/NEJM198704093161501.
    Full Text Link to Item
  - Belldegrun, A., S. L. Topalian, M. Linehan, C. Robertson, and S. A. Rosenberg. “Growth and antitumor activity of tumor-involved draining lymph node cells versus tumor-infiltrating lymphocytes from patients with renal cell cancer.” Surgical Forum 38 (January 1, 1987): 688–90.
  - Robertson, C. N., R. Riefkohl, and G. D. Webster. “Use of the rectus abdominis muscle flap in urological reconstructive procedures.” J Urol 135, no. 5 (May 1986): 963–65. https://doi.org/10.1016/s0022-5347(17)45938-6.
    Full Text Link to Item
  - Robertson, C. N., and L. R. King. “Bladder substitution in children.” Urol Clin North Am 13, no. 2 (May 1986): 333–44.
    Link to Item
  - Belldegrun, A., W. M. Linehan, C. N. Robertson, and S. A. Rosenberg. “Isolation and characterization of lymphocytes infiltrating human renal cell cancer: Possible application for therapeutic adoptive immunotherapy.” Surgical Forum 37 (January 1, 1986): 671–73.
  - Robertson, C. N., C. N. SantoraA., C. Liang, and M. Linehan. “Human recombinant TNF-mediates bone resorption in vitro.” Surgical Forum 37 (January 1, 1986): 669–70.
  - King, L. R., C. N. Robertson, and R. A. Bertram. “A new technique for the prevention of reflux in those undergoing bladder substitution or undiversion using bowel segments.” World Journal of Urology 3, no. 3 (December 1, 1985): 194–96. https://doi.org/10.1007/BF00326993.
    Full Text
  - Walther, P. J., C. N. Robertson, and D. F. Paulson. “Lethal complications of standard self-retaining ureteral stents in patients with ileal conduit urinary diversion.” J Urol 133, no. 5 (May 1985): 851–53. https://doi.org/10.1016/s0022-5347(17)49255-x.
    Full Text Link to Item
  - Webster, G. D., and C. N. Robertson. “The vascularized skin island urethroplasty: its role and results in urethral stricture management.” J Urol 133, no. 1 (January 1985): 31–33. https://doi.org/10.1016/s0022-5347(17)48772-6.
    Full Text Link to Item
- Book Sections
  - Robertson, C. N. “Prostate cancer treatment options for men with significant urinary symptoms and enlarged prostates.” In Prostate Cancer: Clinical Case Scenarios, 75–80, 2018. https://doi.org/10.1007/978-3-319-78646-9_6.
    Full Text
- Other Articles
  - Tang, P., L. Sun, M. A. Uhlman, C. N. Robertson, T. J. Polascik, and J. W. Moul. “Re: Prostate-specific antigen velocity based risk-adapted discontinuation of prostate cancer screening in elderly men.” Journal of Urology, November 1, 2011. https://doi.org/10.1016/j.juro.2011.07.063.
    Full Text
  - Walsh, Patrick C. “Re: Salvage radiation in men after prostate-specific antigen failure and the risk of death.” J Urol, November 2011. https://doi.org/10.1016/j.juro.2011.08.056.
    Full Text Link to Item
  - Zhong, P., F. Xing, X. Huang, H. Zhu, H. W. Lo, X. Zhong, S. Pruitt, and C. Robertson. “HIFU as a neoadjuvant therapy in cancer treatment.” Aip Conference Proceedings, October 13, 2011. https://doi.org/10.1063/1.3607920.
    Full Text
  - Iselin, C. E., C. N. Robertson, G. D. Webster, J. Vieweg, and D. F. Paulson. “Selection criteria for urethral preservation.” British Journal of Urology, December 1, 1997.
  - Demark-Wahnefried, W., D. F. Paulson, C. N. Robertson, E. E. Anderson, M. R. Conaway, and B. K. Rimer. “Body dimension differences in men with or without prostate cancer.” J Natl Cancer Inst, September 2, 1992. https://doi.org/10.1093/jnci/84.17.1363.
    Full Text Link to Item
- Conference Papers
  - Baco, E., A. Blana, V. Berge, C. Chaussy, R. Ganzer, S. Crouzet, G. Pasticier, et al. “Age stratified outcomes after primary HIFU for organ localized prostate cancer in a series of 5206 patients.” In Scandinavian Journal of Urology, 47:53–53. INFORMA HEALTHCARE, 2013.
    Link to Item
  - Bassett, Mitchell, Michael Abern, Lionel Lloyds Banez, Michael Ferrandino, Cary N. Robertson, Brant Allen Inman, Thomas Polascik, Stephen J. Freedland, Philip John Walther, and Judd W. Moul. “African American race to predict for earlier failure of active surveillance: Results from the Duke Prostate Center.” In Journal of Clinical Oncology, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012.
    Link to Item
  - Robertson, Cary N., John Francis Ward, Sebastien Crouzet, Stephen C. W. Brown, Victor Berge, Christian G. Chaussy, Roman Ganzer, et al. “Biochemical survival and morbidity of high-intensity focused ultrasound (HIFU) as a primary monotherapy for low-risk localized prostate cancer: Outcomes from the @-registry following the ENLIGHT trial inclusion criteria.” In Journal of Clinical Oncology, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012.
    Link to Item
  - Singh, Abhay A., Lionel Lloyds Banez, Leah Gerber, Stephen J. Freedland, Cary N. Robertson, Michael Ferrandino, Thomas Polascik, Philip John Walther, and Judd W. Moul. “Perineural versus lymphovascular invasion: Which is a better marker for unfavorable biochemical outcomes following prostatectomy? Results from the Duke Prostate Center Database.” In Journal of Clinical Oncology, Vol. 30. AMER SOC CLINICAL ONCOLOGY, 2012. https://doi.org/10.1200/jco.2012.30.5_suppl.34.
    Full Text Link to Item
  - Blana, A., V. Berge, S. Brown, C. Chaussy, R. Ganzer, S. Crouzet, G. Pasticier, et al. “Localized prostate cancer control with primary HIFU therapy: Outcomes from 5663 men followed with the @-registry.” In European Urology Supplements, 11:E979-U53. ELSEVIER SCIENCE BV, 2012.
    Link to Item
  - Koontz, B. F., L. Gerber, L. L. Bañez, I. T. Degirmenci, Z. Vujaskovic, M. S. Anscher, C. N. Robertson, T. J. Polascik, J. W. Moul, and W. R. Lee. “3D Conformal and Intensity Modulated Radiotherapy to the Prostate Bed have Similar Biochemical Outcomes.” In International Journal of Radiation Oncology*Biology*Physics, 81:S406–7. Elsevier BV, 2011. https://doi.org/10.1016/j.ijrobp.2011.06.659.
    Full Text
  - Koontz, B. F., W. R. Lee, Z. Vujaskovic, M. Carroll, B. P. Quaranta, M. S. Anscher, C. N. Robertson, T. J. Polascik, and J. W. Moul. “Neoadjuvant Radiotherapy plus Prostatectomy for High Risk Prostate Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 81:S397–S397. Elsevier BV, 2011. https://doi.org/10.1016/j.ijrobp.2011.06.640.
    Full Text
  - Wattson, D. A., M. Chen, J. W. Moul, B. J. Moran, D. E. Dosoretz, C. N. Robertson, T. J. Polascik, M. H. Braccioforte, S. A. Salenius, and A. V. D’Amico. “The Number of High-Risk Factors and the Risk of Prostate Cancer-Specific Mortality Following Radical Prostatectomy or Brachytherapy.” In International Journal of Radiation Oncology*Biology*Physics, 81:S434–S434. Elsevier BV, 2011. https://doi.org/10.1016/j.ijrobp.2011.06.716.
    Full Text
  - Bañez, Lionel L., Cathrine Hoyo, Elizabeth M. Masko, Elizabeth E. Calloway, Kathleen H. Shuler, Kathryn A. Newman, Alexis R. Gaines, Stephen J. Freedland, and Cary N. Robertson. “605 COMBINATION OF ADH GENE POLYMORPHISM AND ALCOHOL CONSUMPTION CONSTITUTES A NOVEL PROSTATE CANCER RISK FACTOR IN AFRICAN-AMERICAN MEN.” In Journal of Urology, Vol. 185. Ovid Technologies (Wolters Kluwer Health), 2011. https://doi.org/10.1016/j.juro.2011.02.1458.
    Full Text
  - Calloway, Elizabeth E., David I. Chu, Leah Gerber, Jean-Alfred Thomas, Cary N. Robertson, Thomas J. Polascik, Judd W. Moul, and Lionel L. Bañez. “1204 HEIGHT AND THE RISK FOR AGGRESSIVE PROSTATE CANCER AT THE TIME OF BIOPSY–RESULTS FROM THE DUKE PROSTATE CENTER DATABASE.” In Journal of Urology, Vol. 185. Ovid Technologies (Wolters Kluwer Health), 2011. https://doi.org/10.1016/j.juro.2011.02.839.
    Full Text
  - Gerber, Leah, Lionel L. Bãnez, Stephen J. Freedland, Donghua Xie, Jim J. Qi, Thomas J. Polascik, Cary N. Robertson, and Judd W. Moul. “335 DIABETES MELLITUS AND THE RISK OF HIGH-GRADE PROSTATE CANCER: RESULTS FROM THE DUKE PROSTATE CENTER.” In Journal of Urology, Vol. 185. Ovid Technologies (Wolters Kluwer Health), 2011. https://doi.org/10.1016/j.juro.2011.02.419.
    Full Text
  - Masko, Elizabeth M., Daniel M. Moreira, Lionel L. Bañez, Cathrine Hoyo, Delores J. Grant, Elizabeth E. Calloway, Kathleen H. Shuler, et al. “1613 GENETIC VARIATION IN OBESITY-RELATED GENES ADBR2, ADBR3, GHRL, HSD11B1, AND SHC1 AND RISK OF PROSTATE CANCER: A VA CASE-CONTROL STUDY.” In Journal of Urology, Vol. 185. Ovid Technologies (Wolters Kluwer Health), 2011. https://doi.org/10.1016/j.juro.2011.02.1721.
    Full Text
  - Blana, A., C. N. Robertson, G. N. Conti, R. Ganzer, S. Thüroff, J. F. Watd, S. C. W. Brown, A. Gelet, G. Pasticier, and F. J. Murat. “942 TOTAL HIFU AS A PRIMARY THERAPY FOR LOCALISED PROSTATE CANCER: OUTCOMES FROM THE @-REGISTRY DATABASE.” In European Urology Supplements, 9:296–296. Elsevier BV, 2010. https://doi.org/10.1016/s1569-9056(10)60922-0.
    Full Text
  - Ganzer, R., S. C. W. Brown, G. N. Conti, F. J. Murat, G. Pasticier, A. Gelet, C. N. Robertson, S. Thueroff, J. F. Ward, and A. Blana. “941 CORRELATION OF PSA-NADIR AND BIOCHEMICAL FAILURE AFTER HIGH-INTENSITY FOCUSSED ULTRASOUND (HIFU) OF LOCALIZED PROSTATE CANCER BASED ON THE STUTTGART FAILURE CRITERIA-ANALYSIS FROM THE @-REGISTRY.” In European Urology Supplements, 9:296–296. Elsevier BV, 2010. https://doi.org/10.1016/s1569-9056(10)60921-9.
    Full Text
  - Koontz, Bridget F., Brian P. Quaranta, Madelaine Carroll, Zeljko Vujaskovic, W Robert Lee, Cary N. Robertson, Thomas J. Polascik, Mitchell S. Anscher, and Judd W. Moul. “PHASE I TRIAL OF PROSTATECTOMY AFTER PLANNED PRE-OPERATIVE RADIOTHERAPY FOR HIGH RISK LOCALIZED PROSTATE CANCER: PRELIMINARY RESULTS.” In The Journal of Urology, 181:713–713. Ovid Technologies (Wolters Kluwer Health), 2009. https://doi.org/10.1016/s0022-5347(09)61992-3.
    Full Text
  - Blana, A., S. C. W. Brown, C. Chaussy, G. N. Conti, J. A. Eastham, R. Ganzer, A. Gelet, et al. “DEFINING BIOCHEMICAL FAILURE FOLLOWING HIGH INTENSITY FOCUSED ULTRASOUND OF THE PROSTATE: THE STUTTGART DEFINITION.” In European Urology Supplements, 8:333–333. ELSEVIER SCIENCE BV, 2009.
    Link to Item
  - Blana, A., S. C. W. Brown, C. Chaussy, G. N. Conti, J. A. Eastham, R. Ganzer, F. J. Murat, et al. “PRIMARY PROSTATE HIFU WITHOUT PRETREATMENT HORMONE THERAPY: BIOCHEMICAL SURVIVAL OF 763 PATIENTS TRACKED WITH THE @-REGISTRY.” In European Urology Supplements, 8:333–333. ELSEVIER SCIENCE BV, 2009.
    Link to Item
  - Moul, Judd W., Leon Sun, Cary N. Robertson, Craig F. Donatucci, David M. Albala, Phillip J. Walther, Vladimir Mouraviev, Florian R. Schroeck, and Thomas J. Polascik. “OLDER MEN ASSOCIATED WITH ADVANCED DISEASE AND POOR OUTCOME: AN ANALYSIS OF 14601 PROSTATE CANCER MEN IN DUKE PROSTATE CENTER.” In Journal of Urology, 179:641–641. Ovid Technologies (Wolters Kluwer Health), 2008. https://doi.org/10.1016/s0022-5347(08)61875-3.
    Full Text
  - Sun, Leon, Kevin C. Zorn, David M. Albala, Sergey A. Shikanov, Gregory P. Zagaja, Arieh L. Shalhav, Cary N. Robertson, et al. “PRE-TREATMENT FACTORS PREDICTIVE OF POSITIVE SURGICAL MARGIN IN CONTEMPORARY RADICAL PROSTATECTOMIES.” In Journal of Urology, 179:250–250. Ovid Technologies (Wolters Kluwer Health), 2008. https://doi.org/10.1016/s0022-5347(08)60724-7.
    Full Text
  - Proia, Alan D., Leon L. Sun, Kathryn R. Perkinson, Thomas J. Polascik, Vladimir Mouraviev, Craig F. Donatucci, Cary N. Robertson, et al. “262: KI-67: A Potential Prognostic Biomarker for PSA Recurrence?” In Journal of Urology, 175:87–87. Ovid Technologies (Wolters Kluwer Health), 2006. https://doi.org/10.1016/s0022-5347(18)32529-1.
    Full Text
  - Smith, J. S., C. N. Robertson, E. C. Clipp, D. Iden, and I. M. Lipkus. “Longitudinal assessment of quality of life and disease uncertainty in patients undergoing radical prostatectomy and their spouses/partners.” In Journal of Urology, 169:34–34. LIPPINCOTT WILLIAMS & WILKINS, 2003.
    Link to Item
  - Demark-Wahnefried, W., T. J. Polascik, C. N. Robertson, P. J. Walther, and D. F. Paulson. “Effects of a low fat, flaxseed-supplemented diet on men with prostatic intraepithelial neoplasia (PIN) or atypia.” In Cancer Epidemiology Biomarkers & Prevention, 11:1171S-1171S. AMER ASSOC CANCER RESEARCH, 2002.
    Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Previous Appointments & Affiliations

In the News

Global Scholarship

Research

Selected Grants

External Relationships

Selected Publications

Academic Articles

Book Sections

Other Articles

Conference Papers